Skip to main content
. 2021 Sep 9;31(3):423–439. doi: 10.1093/hmg/ddab262

Figure 7.

Figure 7

Cell survival assays in HT22 cells and HT22 cells transfected with mutant APP cDNA. (A) Cell survival was significantly decreased in mutant APP cells (P = 0.0001) relative to control HT22 cells. However, cell survival was increased in mitophagy enhancers treated mutant APP cells (nicotinamide P = 0.0001 and urolithin A P = 0.0001) relative to mitophagy-enhancer-untreated mutant APP cells.